Literature DB >> 28954710

Mechanisms of anti-cancer effects of ascorbate: Cytotoxic activity and epigenetic modulation.

Domenico Mastrangelo1, Elvira Pelosi2, Germana Castelli2, Francesco Lo-Coco3, Ugo Testa4.   

Abstract

Vitamin C (Vit C or Ascorbate) is essential for many fundamental biochemical processes. Vit C is an essential nutrient with redox functions at normal physiologic concentrations. The main physiologic function of this vitamin is related to its capacity to act as a co-factor for a large family of enzymes, collectively known as Fe and 2-oxoglutarate-dependent dioxygenases. It also modulates epigenetic gene expression through the control of TET enzymes activity. Vit C also has several biological properties allowing to restore the deregulated epigenetic response observed in many tumors. High-dose Vit C has been investigated as a treatment for cancer patients since the 1969. Pharmacologic ascorbate acts as a pro-drug for hydrogen peroxide formation (H2O2) and, through this mechanism, kills cancer cells. To achieve high in vivo concentrations, Ascorbate must be injected by i.v. route. Initial clinical studies of Ascorbate cancer treatment have provided encouraging results, not confirmed in subsequent studies. Recent clinical studies using i.v. injection of high-dose Ascorbate have renewed the interest in the field, showing that significant anti-tumor activity. Pre-clinical studies have led to identify tumors sensitive to Ascorbate that could potentially benefit from this treatment either through an epigenetic modulator effect or through tumor killing by oxidative stress.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28954710     DOI: 10.1016/j.bcmd.2017.09.005

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  21 in total

Review 1.  Targeting cancer vulnerabilities with high-dose vitamin C.

Authors:  Bryan Ngo; Justin M Van Riper; Lewis C Cantley; Jihye Yun
Journal:  Nat Rev Cancer       Date:  2019-05       Impact factor: 60.716

Review 2.  Molecular Probes, Chemosensors, and Nanosensors for Optical Detection of Biorelevant Molecules and Ions in Aqueous Media and Biofluids.

Authors:  Joana Krämer; Rui Kang; Laura M Grimm; Luisa De Cola; Pierre Picchetti; Frank Biedermann
Journal:  Chem Rev       Date:  2022-01-07       Impact factor: 60.622

3.  No Reported Renal Stones with Intravenous Vitamin C Administration: A Prospective Case Series Study.

Authors:  Melissa Prier; Anitra C Carr; Nicola Baillie
Journal:  Antioxidants (Basel)       Date:  2018-05-21

4.  Antitumoral effects of pharmacological ascorbate on gastric cancer cells: GLUT1 expression may not tell the whole story.

Authors:  Alessandro Corti; Eugenia Belcastro; Alfonso Pompella
Journal:  Theranostics       Date:  2018-11-15       Impact factor: 11.556

Review 5.  Targeted Tumor Therapy Remixed-An Update on the Use of Small-Molecule Drugs in Combination Therapies.

Authors:  Martina V Gatzka
Journal:  Cancers (Basel)       Date:  2018-05-24       Impact factor: 6.639

Review 6.  Vitamin C and immune cell function in inflammation and cancer.

Authors:  Abel Ang; Juliet M Pullar; Margaret J Currie; Margreet C M Vissers
Journal:  Biochem Soc Trans       Date:  2018-10-08       Impact factor: 5.407

7.  Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer.

Authors:  Anthony J Bazzan; George Zabrecky; Nancy Wintering; Andrew B Newberg; Daniel A Monti
Journal:  Integr Cancer Ther       Date:  2018-05-17       Impact factor: 3.279

8.  Anti-parasitic effect of vitamin C alone and in combination with benznidazole against Trypanosoma cruzi.

Authors:  Vanesa Puente; Agostina Demaria; Fernanda M Frank; Alcira Batlle; Maria Elisa Lombardo
Journal:  PLoS Negl Trop Dis       Date:  2018-09-21

Review 9.  Potential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence.

Authors:  Margreet C M Vissers; Andrew B Das
Journal:  Front Physiol       Date:  2018-07-03       Impact factor: 4.566

10.  Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid Leukaemia.

Authors:  Mike N Foster; Anitra C Carr; Alina Antony; Selene Peng; Mike G Fitzpatrick
Journal:  Antioxidants (Basel)       Date:  2018-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.